Prognostic factors for survival among patients with primary bone sarcomas of small bones

Zhan Wang(Qinghai University), Zhaoming Ye(Second Affiliated Hospital of Zhejiang University), Yong Li(Hebei Medical University), Peng Lin(Second Affiliated Hospital of Zhejiang University), Lingling Sun(Second Affiliated Hospital of Zhejiang University), Yan Wu(Second Affiliated Hospital of Zhejiang University), Xiaobo Yan(Zhejiang University), Nong Lin(Zhejiang University), Hao Qu(Second Affiliated Hospital of Zhejiang University), Hengyuan Li(Second Affiliated Hospital of Zhejiang University), Meng Liu(AbbVie (United States)), Shu Li(Zhejiang University), Xin Huang(Second Affiliated Hospital of Zhejiang University), Binghao Li(Second Affiliated Hospital of Zhejiang University), Weibo Pan(Zhejiang University)
Cancer Management and Research
May 1, 2018
10.2147/cmar.s163229
Cited by 31

Related Papers

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
|The Lancet|2021|538
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy
|Nature|2012|306
Visible light photocatalysis of dye-sensitized TiO2: The selective aerobic oxidation of amines to imines
|Applied Catalysis B: Environmental|2017|162
α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease
|Neuroscience Letters|2018|161